NASDAQ:ARDS

Aridis Pharmaceuticals Stock Signals

etoro logo Buy ARDS
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Aridis Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 81 days ( 0 %
Last Price $0.0002 0 %
Performance History
7 Days
$0.0002 $0.0002
0%
30 Days
$0.0029 $0.0002
-92.98%
12 Mos
$0.0001 $0.0002
100.00%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 44.59
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0002 - $0.0002
Trend - 3 mos 58.37 % High Width: 735.69 %
Pred. range - 3 mos $0.0007 - $0.0058 Low 249.21 % - 2,818.29 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jun 04, 2026 - 12 days
RSI Short Pivot Signal Sell Very Low Jun 04, 2026 - 12 days
Short MA 3 mos Buy Low Jun 11, 2026 - 7 days
Long MA 3 mos Sell Medium Jun 03, 2026 - 13 days
Short/Long MA 3 mos Sell Medium Jun 08, 2026 - 10 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 39.76
Signal Type Signal Value Importance Data
Trend - 12 mos 39.11 % Very High Width: 2,462.74 %
Pred. range - 12 mos N/A - $0.0044 High -100.00 % - 2,120.36 %
Short MA 12 mos Sell Very High Jun 03, 2026 - 13 days
Long MA 12 mos Sell Very High Jun 03, 2026 - 13 days
Short/Long MA 12 mos Buy Very High May 19, 2026 - 23 days
Pivot Long Buy Low Jun 04, 2026 - 12 days
RSI Long Pivot Signal Sell Low Jun 15, 2026 - 5 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ARIDIS PHARMACEUTICALS INC.
Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE